Seizo Okauchi

Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice

Seizo Okauchi, Masashi Shimoda, Atsushi Obata et al. · Biochemical and Biophysical Research Communications · 2015 · 62 citations

Medicine, Endocrinology, Pharmacology +17

Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes

Tomohiko Kimura, Hideaki Kaneto, Masashi Shimoda et al. · Molecular and Cellular Endocrinology · 2014 · 59 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Protective effects of the SGLT2 inhibitor luseogliflozin on pancreatic β‐cells in <i>db/db</i> mice: The earlier and longer, the better

Tomohiko Kimura, Atsushi Obata, Masashi Shimoda et al. · Diabetes Obesity and Metabolism · 2018 · 52 citations

Medicine, Endocrinology, Pharmacology +17

Down-regulation of vascular GLP-1 receptor expression in human subjects with obesity

Tomohiko Kimura, Atsushi Obata, Masashi Shimoda et al. · Scientific Reports · 2018 · 32 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Decreased glucagon-like peptide 1 receptor expression in endothelial and smooth muscle cells in diabetic <i>db/db</i> mice: TCF7L2 is a possible regulator of the vascular glucagon-like peptide 1 receptor

Tomohiko Kimura, Atsushi Obata, Masashi Shimoda et al. · Diabetes and Vascular Disease Research · 2017 · 23 citations · Full text

Life Sciences, Endocrinology, Physiology +17